The development of combination antiretroviral therapy (cART) has achieved the suppression of viral replication and the increase in CD4+ T cell count in the majority of patients, leading to a significant decrease in morbidity of AIDS and mortality (Vieillard et al., 2016; Saag et al., 2020). Here, CD4 is linked to AIDS.